Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04726878 | ESP in Breast Surgery Due to Cancer | completed | Phase 4 | 75 | Medical University of LublinOTHER | 1 | Nov 9, 2021 | clinicaltrials |
| NCT02447328 | A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer | completed | Phase 4 | 83 | AstraZenecaINDUSTRY | 1 | Sep 5, 2021 | clinicaltrials |
| NCT04031885 | A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer | terminated | Phase 4 | 4 | Eli Lilly and CompanyINDUSTRY | 2 | Aug 24, 2021 | clinicaltrials |
| NCT04136782 | Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer | recruiting | Phase 4 | 110 | Shengjing HospitalOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT04137640 | Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy | unknown | Phase 4 | 152 | Shengjing HospitalOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT03511378 | Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer | completed | Phase 4 | 138 | Lupin Ltd.INDUSTRY | 1 | Jun 15, 2021 | clinicaltrials |
| NCT00688909 | Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer(REAL) | completed | Phase 4 | 261 | Novartis PharmaceuticalsINDUSTRY | 1 | Jun 9, 2021 | clinicaltrials |
| NCT04487912 | Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer | withdrawn | Phase 4 | 0 | University Hospital, GhentOTHER | 1 | May 14, 2021 | clinicaltrials |
| NCT03038152 | Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery | completed | Phase 4 | 54 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT02864030 | PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment | completed | Phase 4 | 200 | Oncologia Medica dell'Ospedale FatebenefratelliOTHER_GOV | 1 | Mar 4, 2021 | clinicaltrials |
| NCT04029467 | Effect of Dexmedetomidine on the Duration of Pain Control in ESP Block for Breast Surgery | unknown | Phase 4 | 44 | Lebanese American UniversityOTHER | 1 | Feb 23, 2021 | clinicaltrials |
| NCT03738527 | SEroma Reduction pOst MAstectomy "SEROMA Study"(SEROMA) | unknown | Phase 4 | 100 | Hamilton Health Sciences CorporationOTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT02721433 | 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases(REaCT-BTA) | completed | Phase 4 | 263 | Ottawa Hospital Research InstituteOTHER | 1 | Dec 2, 2020 | clinicaltrials |
| NCT04009941 | Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer | completed | Phase 4 | 104 | Peking UniversityOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| NCT02822196 | Serratus Anterior Muscle Plane Block vsThoracic Paravertebral Block For Unilateral Mastectomies | withdrawn | Phase 4 | 0 | The University of Texas Health Science Center, HoustonOTHER | 1 | Sep 16, 2020 | clinicaltrials |
| NCT03397914 | Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections | completed | Phase 4 | 70 | National Cancer Institute, EgyptOTHER | 1 | Sep 16, 2020 | clinicaltrials |
| NCT02502864 | Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide | completed | Phase 4 | 9 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 11, 2020 | clinicaltrials |
| NCT02287675 | Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer(Lymphoseek) | completed | Phase 4 | 40 | Kettering Health NetworkOTHER | 1 | Jul 28, 2020 | clinicaltrials |
| NCT04434404 | Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy | completed | Phase 4 | 83 | Horus UniversityOTHER | 1 | Jun 16, 2020 | clinicaltrials |
| NCT02816112 | Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia(REaCT-TC2) | completed | Phase 4 | 458 | Ottawa Hospital Research InstituteOTHER | 1 | May 27, 2020 | clinicaltrials |
| NCT02005770 | Anesthesia and Circulating Tumor Cells in Breast Cancer | completed | Phase 4 | 221 | University of ZurichOTHER | 1 | Apr 14, 2020 | clinicaltrials |
| NCT04261179 | Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer(SENTINELSEEK) | unknown | Phase 4 | 30 | Anna CrucetaOTHER | 1 | Feb 20, 2020 | clinicaltrials |
| NCT04218149 | Serratus Plane Block vs Erector Spinae Plane Block on Postoperative Analgesia in Patients Undergoing Unilateral Breast Surgery | completed | Phase 4 | 70 | Sisli Hamidiye Etfal Training and Research HospitalOTHER | 1 | Jan 31, 2020 | clinicaltrials |
| NCT03348696 | Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for TAPS in Breast Cancer Patients(REaCT-TAPS) | completed | Phase 4 | 124 | Ottawa Hospital Research InstituteOTHER | 1 | Jan 9, 2020 | clinicaltrials |
| NCT03305757 | Seroma Reduction After Mastectomy(SAM) | completed | Phase 4 | 339 | Zuyderland Medisch CentrumOTHER | 1 | Dec 3, 2019 | clinicaltrials |
| NCT03125941 | High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Mastectomy(DEX-MAS) | completed | Phase 4 | 130 | Rigshospitalet, DenmarkOTHER | 1 | Dec 2, 2019 | clinicaltrials |
| NCT04182568 | Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer | unknown | Phase 4 | 100 | Xijing HospitalOTHER | 1 | Dec 2, 2019 | clinicaltrials |
| NCT02445586 | Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer | completed | Phase 4 | 52 | Hoffmann-La RocheINDUSTRY | 1 | Oct 29, 2019 | clinicaltrials |
| NCT04116021 | The Analgesic Efficacy of the Pectoral Nerves Block Versus Local Anesthetic Infiltration After Mastectomy(PECS) | unknown | Phase 4 | 50 | Hôpital du ValaisOTHER | 0 | Oct 4, 2019 | clinicaltrials |
| NCT02344940 | Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer(TTOS) | completed | Phase 4 | 104 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Sep 24, 2019 | clinicaltrials |
| NCT03456661 | Comparison Between Levobupivacaine and Levobupivacaine With Dexmedetomidine in Ultrasound Guided Pectoral Nerve Block | terminated | Phase 4 | 40 | University Hospital, AntwerpOTHER | 1 | Sep 20, 2019 | clinicaltrials |
| NCT02816164 | A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia(REaCT-G2) | completed | Phase 4 | 324 | Ottawa Hospital Research InstituteOTHER | 1 | Sep 6, 2019 | clinicaltrials |
| NCT03988114 | A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer(proMONARCH) | withdrawn | Phase 4 | 0 | Eli Lilly and CompanyINDUSTRY | 9 | Sep 6, 2019 | clinicaltrials |
| NCT00756717 | Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer(MK-0752) | completed | Phase 4 | 22 | Loyola UniversityOTHER | 1 | Sep 4, 2019 | clinicaltrials |
| NCT03123770 | Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer Patients(ESNDBCP) | unknown | Phase 4 | 384 | Zhejiang UniversityOTHER | 1 | Apr 10, 2019 | clinicaltrials |
| NCT02590315 | Tomosynthesis Versus Digital Mammography in a Population-based Screening Program(ProteusDonna) | unknown | Phase 4 | 92,000 | Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica PiemonteOTHER | 1 | Jan 31, 2019 | clinicaltrials |
| NCT03799679 | Albumin-Bound Paclitaxel Followed by Epirubicin in Combination With Cyclophosphamide in Triple Negative Breast Cancer | unknown | Phase 4 | 60 | Fudan UniversityOTHER | 1 | Jan 10, 2019 | clinicaltrials |
| NCT03799757 | Using Bupivacaine Locally in the Mastectomy Drains to Control Postoperative Pain | completed | Phase 4 | 168 | Alexandria UniversityOTHER | 1 | Jan 10, 2019 | clinicaltrials |
| NCT03238703 | Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer | withdrawn | Phase 4 | 0 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 27, 2018 | clinicaltrials |
| NCT03676114 | Effect of Perioperative Low Dose Ketamine on Postoperative Recovery in Patients Undergoing Breast Cancer Surgery | unknown | Phase 4 | 100 | Han YuanOTHER | 1 | Sep 21, 2018 | clinicaltrials |
| NCT00812864 | Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥ 75 Years)(capagec) | completed | Phase 4 | 20 | University Hospital, LimogesOTHER | 1 | Aug 28, 2018 | clinicaltrials |
| NCT03199560 | Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy | unknown | Phase 4 | 86 | Memorial Health University Medical CenterOTHER | 1 | Aug 24, 2018 | clinicaltrials |
| NCT01537029 | Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide | completed | Phase 4 | 15 | Texas Tech University Health Sciences CenterOTHER | 1 | Aug 22, 2018 | clinicaltrials |
| NCT03591549 | Fulvestrant in Metastatic Breast Cancer | unknown | Phase 4 | 30 | Assiut UniversityOTHER | 0 | Jul 23, 2018 | clinicaltrials |
| NCT00772824 | Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients | completed | Phase 4 | 23 | Banaras Hindu UniversityOTHER | 1 | Jul 17, 2018 | clinicaltrials |
| NCT01501487 | MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I(MINT) | completed | Phase 4 | 226 | AgendiaINDUSTRY | 1 | Jun 28, 2018 | clinicaltrials |
| NCT01094184 | A Study of Bevacizumab With Taxane Therapy in Participants With Triple Negative Breast Cancer(BATMAN) | completed | Phase 4 | 49 | Hoffmann-La RocheINDUSTRY | 1 | Mar 22, 2018 | clinicaltrials |
| NCT03465202 | Association of Capecitabine Pharmacokinetics and Toxicity With Aging | unknown | Phase 4 | 100 | Newcastle-upon-Tyne Hospitals NHS TrustOTHER | 0 | Mar 14, 2018 | clinicaltrials |
| NCT03384511 | The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. | completed | Phase 4 | 38 | Shandong Cancer Hospital and InstituteOTHER | 1 | Feb 20, 2018 | clinicaltrials |
Data updated 22 days agoSource updated Nov 9, 2021source: clinicaltrials